Inventor
Argyrios G. Arvanitis
Inventor
Kennett Square, PA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes21%
C07HSugars6%
C07BGeneral methods of organic chemistry2%
C12NMicroorganisms or enzymes2%
PatentTitleYear
10,463,667Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile20199,512,161'Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile'20169,359,358'Cyclohexyl azetidine derivatives as JAK inhibitors'20169,334,274'N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors'20168,889,697'Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile'20148,841,318'Substituted heterocycles as janus kinase inhibitors'20148,835,423'Azepine inhibitors of janus kinases'20148,748,401'Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile'20148,716,303'N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors'20148,563,541'Azepine inhibitors of Janus kinases'20138,513,270'Substituted heterocycles as Janus kinase inhibitors'20138,486,902'Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile'20138,415,362'Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors'20137,112,585'Pyrimidine derivatives as corticotropin releasing factor inhibitors'20067,067,658'Pyridino and pyrimidino pyrazinones'20067,045,529'Imidazopyrimidinyl and imidazopyri dinyl derivatives'20067,030,145'Pyridinyl derivatives for the treatment of depression'20066,969,721'Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors'20056,596,729'Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors'20036,525,056'Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2006Patents assigned to BRISTOL MYERS SQUIBB CO (4)· patent assignee history
2003–2019Based in Kennett Square, PA, US· patent location history
2013–2019Patents assigned to INCYTE CORP (13)· patent assignee history
2013–2016Patents assigned to ARVANITIS ARGYRIOS G (8)· patent assignee history
2013–2016Patents assigned to RODGERS JAMES D (8)· patent assignee history
2013–2014Patents assigned to SHEPARD STACEY (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 13 | 2013–2019 |
| ARVANITIS ARGYRIOS Gself | 8 | 2013–2016 |
| RODGERS JAMES D | 8 | 2013–2016 |
| SHEPARD STACEY | 5 | 2013–2014 |
| BRISTOL MYERS SQUIBB CO | 4 | 2003–2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kennett Square, Pennsylvania, US | 20 | 2003–2019 |